Resignation from industry body comes after condemnation of Novo Nordisk over promotional drug campaign
Pinder Sahota has resigned as president of the Association of the British Pharmaceutical Industry amid an ongoing investigation into his company Novo Nordisk for its allegedly “disguised” sponsorship of a promotional drug campaign.
Sahota (pictured) is general manager of the UK arm of Denmark-based global healthcare company Novo Nordisk, which has been investigated by the Prescription Medicines Code of Practice Authority (PMCPA).